Javascript must be enabled to continue!
Non-drug treatment of non-alcoholic fatty liver disease: evaluation of effectiveness with ultrasound steatometry
View through CrossRef
Objective. Evaluation of the effectiveness of non-drug treatment in patients with non-alcoholic fatty liver disease using the method of quantitative ultrasound steatometry.Material and methods. We examined 118 patients aged 18–75 years, including 52 (44 %) men and 66 (56 %) women using a single diagnostic algorithm of four stages: questioning and collecting complaints, assessing the quality of life, clinical examination, non-invasive bioimpedansometry, followed by assessment of fat mass index, ultrasound examination of the liver in the B-mode, quantitative ultrasound steatometry by evaluating the attenuation coefficient of the ultrasonic wave. Individual non-drug therapy is prescribed to patients in the form of an individual program of therapeutic nutrition and physical activity. A dynamic assessment of the decrease in the proportion of adipose tissue and the severity of fatty liver infiltration was carried out at points of 6, 12, 18, 24 months. A liver biopsy followed by histological analysis on an SAF scale was performed in 32 patients.Results. To assess the effectiveness of non-drug treatment in patients, a tendency of reducing the proportion of fat content and the severity of fatty infiltration in the liver was observed. All patients were divided into two groups according to their level of compliance with the prescribed treatment. Decrease in the proportion of adipose tissue in patients with a high level of compliance – up to 76.2 %, in patients with a low level of compliance – up to 89.1 % of the initial values. Decrease in fatty liver infiltration in patients with a high level of compliance – up to 80.2 %, in patients with a low level of compliance – up to 92.1 % of the initial one.Conclusion. Ultrasound steatometry is an informative method for non-alcoholic fatty liver disease screening. The correlation of quantitative ultrasound diagnostics data for steatosis with a biopsy at stage S0 corresponds to r = 0.85; at stage S1 r = 0.72, at S2 r = 0.73, at stage S3 corresponds to r = 0.84, which indicates the high informativity of this method.
Title: Non-drug treatment of non-alcoholic fatty liver disease: evaluation of effectiveness with ultrasound steatometry
Description:
Objective.
Evaluation of the effectiveness of non-drug treatment in patients with non-alcoholic fatty liver disease using the method of quantitative ultrasound steatometry.
Material and methods.
We examined 118 patients aged 18–75 years, including 52 (44 %) men and 66 (56 %) women using a single diagnostic algorithm of four stages: questioning and collecting complaints, assessing the quality of life, clinical examination, non-invasive bioimpedansometry, followed by assessment of fat mass index, ultrasound examination of the liver in the B-mode, quantitative ultrasound steatometry by evaluating the attenuation coefficient of the ultrasonic wave.
Individual non-drug therapy is prescribed to patients in the form of an individual program of therapeutic nutrition and physical activity.
A dynamic assessment of the decrease in the proportion of adipose tissue and the severity of fatty liver infiltration was carried out at points of 6, 12, 18, 24 months.
A liver biopsy followed by histological analysis on an SAF scale was performed in 32 patients.
Results.
To assess the effectiveness of non-drug treatment in patients, a tendency of reducing the proportion of fat content and the severity of fatty infiltration in the liver was observed.
All patients were divided into two groups according to their level of compliance with the prescribed treatment.
Decrease in the proportion of adipose tissue in patients with a high level of compliance – up to 76.
2 %, in patients with a low level of compliance – up to 89.
1 % of the initial values.
Decrease in fatty liver infiltration in patients with a high level of compliance – up to 80.
2 %, in patients with a low level of compliance – up to 92.
1 % of the initial one.
Conclusion.
Ultrasound steatometry is an informative method for non-alcoholic fatty liver disease screening.
The correlation of quantitative ultrasound diagnostics data for steatosis with a biopsy at stage S0 corresponds to r = 0.
85; at stage S1 r = 0.
72, at S2 r = 0.
73, at stage S3 corresponds to r = 0.
84, which indicates the high informativity of this method.
Related Results
NOVEL METHOD FOR QUANTIFYING HEPATIC STEATOSIS IN PATIENTS WITH METABOLICALLY ASSOCIATED FATTY LIVER DISEASE
NOVEL METHOD FOR QUANTIFYING HEPATIC STEATOSIS IN PATIENTS WITH METABOLICALLY ASSOCIATED FATTY LIVER DISEASE
Introduction.The article presents an overview of novel complex algorithm based on methods of ultrasound steatometry, combined elastography and dual-energy X-ray absorbtiometry in “...
Hepatoprotective activity of Ammi majus on CCL4 Induced Albino Mice
Hepatoprotective activity of Ammi majus on CCL4 Induced Albino Mice
This study was amid to evaluate the possible protective effects of the water and alcoholic extract of Ammi majus seeds against liver damage induced in mice by CCL4. The plant was c...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...
On dual-energy X-ray absorbtiometry use in patients with metabolic syndrome and associated fatty liver disease
On dual-energy X-ray absorbtiometry use in patients with metabolic syndrome and associated fatty liver disease
Objective. To demonstrate the possibilities of using dual-energy X-ray absorptiometry in the ‘Whole-Body’ mode in the algorithm for diagnosing and monitoring metabolically associat...
Checklist for the distribution of patients into risk groups for metabolically associated fatty liver disease: features of use in the hospital admissions department
Checklist for the distribution of patients into risk groups for metabolically associated fatty liver disease: features of use in the hospital admissions department
Relevance: due to the widespread prevalence of obesity, metabolic syndrome and associated fatty liver disease, as well as due to the lack of an integrated approach to diagnosing th...
Diagnostic Value of Serum Procollagen Peptide Measurements in Alcoholic Liver Disease
Diagnostic Value of Serum Procollagen Peptide Measurements in Alcoholic Liver Disease
Procollagen type I carboxyterminal and type III aminoterminal peptide concentrations were measured in sera of 60 patients with alcoholic and 14 with nonalcoholic liver disease to s...
The gut-liver axis in fatty liver disease: role played by natural products
The gut-liver axis in fatty liver disease: role played by natural products
Fatty liver disease, a condition characterized by fatty degeneration of the liver, mainly classified as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD),...


